Current Share Price 1.390 RM
MRCB is a leading urban property developer, with a large portfolio of successful integrated commercial and residential developments anchored around transportation hubs.
MRCB was the pioneer of Transit Oriented Development (“TOD”) in Malaysia, through its flagship and award winning Kuala Lumpur Sentral CBD project, which has attracted some of the world’s leading corporations as tenants due to its excellent transportation connectivity. MRCB’s future TOD projects – PJ Sentral Garden City, Penang Sentral, Kwasa Sentral and Cyberjaya City Centre, will feature excellent transportation connectivity at their core. The Group’s Property investment activity is through its 31% equity stake in MRCB-Quill REIT. MRCB owns an urban development land bank of 383 acres, with an estimated gross development value of RM55 billion.
MRCB has announced that it had declare a first and final single tier dividend of 2.75 % per ordinary share, which clearly defines that this is the final amount of dividend, shareholders will be getting.
Company proposed to announced right issue and warrant shares, only to those shareholders whose name appears in the record of Depositors on 21 july 2017 shall be eligible in person or appointed proxies to attend or vote in EGM.
The company’s overall revenue is increasing in 2017 by 16.9%.The company is leading with higher profit before taxation for the financial year quater ended 31 march 2017 was mainly due to the gain of RM 144.9 million derived from the sale of Menara Shell and also due to lower financial cost incurred and higher financial income generated. The effective tax rate of the company is 29.1% for the current financial quarter which is higher than the statutory rate of taxation. After evaluating the financial records of the company, now its a good time for the investors to grab the oppurtunity to invest in this stock.
The current share price is 1.390 RM, and it is expected to reach upto 1.710 RM, thus the investors can invest in this stock as it will move upto 15-18 cents in 3-4 weeks.